
    
      This study aims to obtain safety, tolerability, pharmacokinetic and pharmacodynamic data when
      ONO-7684 is administered orally as single doses and as multiple doses to healthy subjects.
      The study will consist of 2 parts: A single ascending dose (SAD) phase (Part A); a multiple
      ascending dose (MAD) phase (Part B). One cohort of Part A will receive ONO-7684 under both
      fasted and fed conditions to investigate the effect of food.
    
  